Literature DB >> 26272183

Characteristics of liver cancer stem cells and clinical correlations.

Zhuo Cheng1, Xiaofeng Li1, Jin Ding2.   

Abstract

Liver cancer is an aggressive malignant disease with a poor prognosis. Patients with liver cancer are usually diagnosed at an advanced stage and thus miss the opportunity for surgical resection. Chemotherapy and radiofrequency ablation, which target tumor bulk, have exhibited limited therapeutic efficacy to date. Liver cancer stem cells (CSCs) are a small subset of undifferentiated cells existed in liver cancer, which are considered to be responsible for liver cancer initiation, metastasis, relapse and chemoresistance. Elucidating liver CSC characteristics and disclosing their regulatory mechanism might not only deepen our understanding of the pathogenesis of liver cancer but also facilitate the development of diagnostic, prognostic and therapeutic approaches to improve the clinical management of liver cancer. In this review, we will summarize the recent advances in liver CSC research in terms of the origin, identification, regulation and clinical correlation.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cancer stem cell; Chemoresistance; Liver cancer; Self-renewal

Mesh:

Substances:

Year:  2015        PMID: 26272183     DOI: 10.1016/j.canlet.2015.07.041

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  23 in total

1.  The distribution of liver cancer stem cells correlates with the mechanical heterogeneity of liver cancer tissue.

Authors:  Yuchuan Sun; Hong Li; Qiufang Chen; Qing Luo; Guanbin Song
Journal:  Histochem Cell Biol       Date:  2021-03-12       Impact factor: 4.304

2.  Lactonic sophorolipid-induced apoptosis in human HepG2 cells through the Caspase-3 pathway.

Authors:  Xiao Wang; Na Xu; Qinglin Li; Shengqi Chen; Hui Cheng; Mo Yang; Ting Jiang; Jun Chu; Xiaojing Ma; Dengke Yin
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-13       Impact factor: 4.813

3.  Soy protein isolate inhibits hepatic tumor promotion in mice fed a high-fat liquid diet.

Authors:  Kelly E Mercer; Casey F Pulliam; Kim B Pedersen; Leah Hennings; Martin Jj Ronis
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-05

4.  Circular RNA cia-MAF drives self-renewal and metastasis of liver tumor-initiating cells via transcription factor MAFF.

Authors:  Zhenzhen Chen; Tiankun Lu; Lan Huang; Zhiwei Wang; Zhongyi Yan; Yubo Guan; Wenjing Hu; Zusen Fan; Pingping Zhu
Journal:  J Clin Invest       Date:  2021-10-01       Impact factor: 14.808

5.  Tex10 is upregulated and promotes cancer stem cell properties and chemoresistance in hepatocellular carcinoma.

Authors:  Xiaocong Xiang; Li Deng; Rong Xiong; Dongqin Xiao; Zhu Chen; Fei Yang; Kang Liu; Gang Feng
Journal:  Cell Cycle       Date:  2018-07-25       Impact factor: 4.534

6.  The role of CD133 in hepatocellular carcinoma.

Authors:  Fengchao Liu; Yanzhi Qian
Journal:  Cancer Biol Ther       Date:  2021-04-25       Impact factor: 4.742

7.  miR-9-5p facilitates hepatocellular carcinoma cell proliferation, migration and invasion by targeting ESR1.

Authors:  Libing Wang; Mingxin Cui; Daming Cheng; Fengzhi Qu; Jingkun Yu; Yanbin Wei; Ling Cheng; Xiaotang Wu; Xiaogang Liu
Journal:  Mol Cell Biochem       Date:  2020-10-27       Impact factor: 3.396

Review 8.  The evolving concept of liver cancer stem cells.

Authors:  Kouki Nio; Taro Yamashita; Shuichi Kaneko
Journal:  Mol Cancer       Date:  2017-01-30       Impact factor: 27.401

9.  Cancer stemness and metastatic potential of the novel tumor cell line K3: an inner mutated cell of bone marrow-derived mesenchymal stem cells.

Authors:  Hui Qian; Xiaoqing Ding; Jiao Zhang; Fei Mao; Zixuan Sun; Haoyuan Jia; Lei Yin; Mei Wang; Xu Zhang; Bin Zhang; Yongmin Yan; Wei Zhu; Wenrong Xu
Journal:  Oncotarget       Date:  2017-06-13

10.  3-hydroxyanthranic acid increases the sensitivity of hepatocellular carcinoma to sorafenib by decreasing tumor cell stemness.

Authors:  Guifang Gan; Zhaopeng Shi; Dan Liu; Shaoyi Zhang; Hui Zhu; Yugang Wang; Jun Mi
Journal:  Cell Death Discov       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.